Prokaryotics Inc

Prokaryotics Inc. is a start-up biotechnology company based in Union, New Jersey. The company is comprised of seven employees and generates an annual revenue of $7 million. Prokaryotics specializes in the development, manufacturing, and commercialization of novel antibiotic programs. They focus on creating innovative therapeutics targeting both Gram-negative and Gram-positive bacteria. Leveraging expertise acquired from licensing programs from Merck & Co., Inc., Prokaryotics aims to combat the growing global crisis of antibiotic resistance. Their commitment lies in bringing forth solutions to address the pressing issue of multidrug-resistant bacteria. Interested parties can learn more about Prokaryotics Inc. and their antibiotic programs by visiting their website at prokaryotics.com.